Thanks abeta. Did not mean to make it sound so strong. But it helps the argument. :) I am not trying to say it is already approved though. I do think the UK regulator is very positively disposed. But they will look at the full package, wrinkles and all, rare disease, amazing results, challenging new ways of looking at the data that are positive but unconventional, and they will no doubt have eminent people of many perspectives doing so and, as I have always said, they will be "kicking the tires", which is their job. I believe in the end, given past decisions about other treatments that are nowhere near as promising, they will have no choice but to approve. But that's just my lowly opinion. I can't predict the future or outcomes. I simply have come to believe it. And everyone should look at the facts and doe their due diligence and figure out what they believe too, wherever that research leads them.
Market Data 
Markets 
AI
